PMN logo

PMN
ProMIS Neurosciences

830
Mkt Cap
$23.63M
Volume
29,371.00
52W High
$39.75
52W Low
$6.27
PE Ratio
-0.57
PMN Fundamentals
Price
$10.98
Prev Close
$10.85
Open
$10.75
50D MA
$12.61
Beta
0.42
Avg. Volume
43,078.33
EPS (Annual)
-$22.61
P/B
1.62
Rev/Employee
$0.00
$5.84
Loading...
Loading...
News
all
press releases
Promis Neurosciences (PMN) Projected to Post Quarterly Earnings on Monday
Promis Neurosciences (NASDAQ:PMN) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...
News Placeholder
More News
News Placeholder
Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 4,000 Shares of Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Patrick Kirwin purchased 4,000 shares of the stock in a transaction on Wednesday, April 22nd. The shares were bought at an average price...
News Placeholder
Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Promis Neurosciences (NASDAQ:PMN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the four brokerages that are covering the stock, MarketBeat.com reports. One...
News Placeholder
Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 1,000 Shares of Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 1,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was bought at an average cost...
News Placeholder
Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 2,000 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were...
News Placeholder
Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams bought 1,000 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was purchased at an average...
News Placeholder
Promis Neurosciences (NASDAQ:PMN) Insider Buys $25,005.15 in Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) insider Johanne Kaplan bought 1,629 shares of Promis Neurosciences stock in a transaction on Thursday, February 19th. The shares were purchased at...
News Placeholder
Insider Buying: Promis Neurosciences (NASDAQ:PMN) Major Shareholder Acquires 700,741 Shares of Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) major shareholder Abg Management Ltd. bought 700,741 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The...
News Placeholder
ProMIS Neurosciences Secures $175 Mln In Private Financing
(RTTNews) - ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company, has announced on Friday a private investment in public equity financing of up to approximately $175 million...
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available